Cargando…
Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants
SARS-CoV-2 Omicron subvariants have evolved to evade receptor-binding site (RBS) antibodies that exist in diverse individuals as public antibody clones. We rationally selected RBS antibodies resilient to mutations in emerging Omicron subvariants. Y489 was identified as a site of virus vulnerability...
Autores principales: | Moriyama, Saya, Anraku, Yuki, Taminishi, Shunta, Adachi, Yu, Kuroda, Daisuke, Kita, Shunsuke, Higuchi, Yusuke, Kirita, Yuhei, Kotaki, Ryutaro, Tonouchi, Keisuke, Yumoto, Kohei, Suzuki, Tateki, Someya, Taiyou, Fukuhara, Hideo, Kuroda, Yudai, Yamamoto, Tsukasa, Onodera, Taishi, Fukushi, Shuetsu, Maeda, Ken, Nakamura-Uchiyama, Fukumi, Hashiguchi, Takao, Hoshino, Atsushi, Maenaka, Katsumi, Takahashi, Yoshimasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349087/ https://www.ncbi.nlm.nih.gov/pubmed/37452031 http://dx.doi.org/10.1038/s41467-023-39890-8 |
Ejemplares similares
-
A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site
por: Onodera, Taishi, et al.
Publicado: (2021) -
SARS-CoV-2 Omicron-neutralizing memory B-cells are elicited by two doses of BNT162b2 mRNA vaccine
por: Kotaki, Ryutaro, et al.
Publicado: (2022) -
Structural basis for cross-group recognition of an influenza virus hemagglutinin antibody that targets postfusion stabilized epitope
por: Tonouchi, Keisuke, et al.
Publicado: (2023) -
Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2
por: Ohashi, Hirofumi, et al.
Publicado: (2022) -
Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain
por: Takano, Tomohiro, et al.
Publicado: (2023)